Can falling nocturnal glucose prolong arousal through stress-hormone responses?

Nocturnal awakenings are often linked to metabolic shifts during sleep, particularly fluctuations in blood glucose levels that trigger systemic stress responses.

Physiological mechanisms of arousal

• Counter-regulatory hormone surge: Falling nocturnal blood glucose levels prompt a counter-regulatory response, mobilizing epinephrine (adrenaline) and cortisol. Although the sleep state physiologically blunts this neuroendocrine response and shifts the activation threshold downward, a sufficient drop below this threshold triggers a surge that drives acute physiological arousal and awakening.
• Catecholamine clearance pathways: Once an arousal is triggered, catechol-O-methyltransferase (COMT) serves as a primary pathway for terminating epinephrine and norepinephrine signaling. Slower catecholamine clearance—such as that seen in individuals carrying low-activity COMT genotypes (e.g., Met/Met)—degrades these active stress hormones more slowly. This theoretically extends sympathetic and somatic signaling, prolonging the time it takes to return to sleep.

Clinical evidence and clearance effects

• Arousal duration: While the link between nocturnal glucose drops and initial sleep disruption is highly supported, direct empirical evidence linking COMT-driven clearance rates to the specific prolongation of nocturnal arousal remains modest and context-dependent.
• Sleep architecture impact: Population-scale data suggest that COMT genetic variations exert subtle, highly variable effects on sleep-wake architecture rather than serving as primary, standalone drivers of sleep fragmentation.

Bottom line

• Falling blood glucose during sleep triggers a counter-regulatory adrenaline and cortisol surge that drives nocturnal arousal; however, the hypothesis that slower catecholamine clearance (e.g., via low-activity COMT genotypes) prolongs this awake state is highly plausible but lacks definitive clinical validation.